Cross Country Healthcare Dirección

Dirección controles de criterios 2/4

El CEO de Cross Country Healthcare es John Martins , nombrado en Apr 2022, tiene una permanencia de 2.58 años. compensación anual total es $3.51M, compuesta por 24.8% salario y 75.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.47% de las acciones de la empresa, por valor de €1.57M. La antigüedad media del equipo directivo y de la junta directiva es de 3.5 años y 5.2 años, respectivamente.

Información clave

John Martins

Chief Executive Officer (CEO)

US$3.5m

Compensación total

Porcentaje del salario del CEO	24.8%
Permanencia del CEO	2.6yrs
Participación del CEO	0.5%
Permanencia media de la dirección	3.5yrs
Promedio de permanencia en la Junta Directiva	5.2yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de John Martins en comparación con los beneficios de Cross Country Healthcare?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	-US$2m
Jun 30 2024	n/a	n/a	US$8m
Mar 31 2024	n/a	n/a	US$46m
Dec 31 2023	US$4m	US$869k	US$73m
Sep 30 2023	n/a	n/a	US$102m
Jun 30 2023	n/a	n/a	US$124m
Mar 31 2023	n/a	n/a	US$156m
Dec 31 2022	US$3m	US$647k	US$188m
Sep 30 2022	n/a	n/a	US$227m
Jun 30 2022	n/a	n/a	US$216m
Mar 31 2022	n/a	n/a	US$175m
Dec 31 2021	US$1m	US$397k	US$132m

Compensación vs. Mercado: La compensación total de John($USD3.51M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD1.03M).

Compensación vs. Ingresos: La compensación de John ha aumentado mientras la empresa no es rentable.

CEO

John Martins (56 yo)

2.6yrs

Permanencia

US$3,511,756

Compensación

Mr. John A. Martins has been the President, Chief Executive Officer and a Director of Cross-Country Healthcare, Inc. since April 02022. He had been the Group President of Delivery at Cross Country Healthca...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	5.8yrs	US$310.00k	1.99% € 6.6m
John Martins	President	2.6yrs	US$3.51m	0.47% € 1.6m
William Burns	Executive VP & CFO	5.8yrs	US$1.50m	0.73% € 2.4m
Susan Ball	Chief Administrative Officer	20.5yrs	US$1.18m	0.53% € 1.8m
Marc Krug	Group President of Delivery	no data	US$953.25k	0.11% € 351.9k
James Redd	Senior VP & Chief Accounting Officer	2yrs	sin datos	0.056% € 186.1k
Phillip Noe	Chief Information Officer	3.5yrs	sin datos	0.031% € 102.5k
Joshua Vogel	Vice President of Investor Relations	2.7yrs	sin datos	sin datos
Karen Varga-Sinka	Director of Corporate Communications	no data	sin datos	sin datos
Gerald Purgay	Chief Marketing Officer	3.7yrs	sin datos	sin datos
Mark Fortunato	Vice President of Corporate Development	no data	sin datos	sin datos
Colin McDonald	Chief Human Resources Officer	no data	sin datos	0.074% € 244.5k

3.5yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de XXY se considera experimentado (3.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	5.8yrs	US$310.00k	1.99% € 6.6m
John Martins	President	2.6yrs	US$3.51m	0.47% € 1.6m
Mark Perlberg	Independent Director	9.5yrs	US$240.00k	0.28% € 941.2k
W. Cash	Lead Independent Director	23.1yrs	US$268.75k	0.59% € 2.0m
Gale Fitzgerald	Independent Director	17.5yrs	US$237.25k	0.53% € 1.8m
Janice Nevin	Independent Director	4.5yrs	US$225.00k	0.10% € 339.1k
Dwayne Allen	Independent Director	1.8yrs	US$287.50k	0.045% € 149.2k
Venkat Bhamidipati	Independent Director	2yrs	US$231.25k	0.045% € 148.8k

5.2yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: La junta directiva de XXY se considera experimentada (5.2 años de antigüedad promedio).

Cross Country Healthcare Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Insider recently sold €216k worth of stock

Chief Information Officer recently sold €126k worth of stock

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Recent updates

Third quarter 2024 earnings released: EPS: US$0.077 (vs US$0.37 in 3Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Cross Country Healthcare, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Insider recently sold €216k worth of stock

Second quarter 2024 earnings released: US$0.47 loss per share (vs US$0.60 profit in 2Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 16%

Cross Country Healthcare, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chief Information Officer recently sold €126k worth of stock

First quarter 2024 earnings released: EPS: US$0.079 (vs US$0.82 in 1Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey

Cross Country Healthcare, Inc. to Report Q1, 2024 Results on May 01, 2024

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

New minor risk - Share price stability

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$2.07 (vs US$5.09 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Now 23% undervalued after recent price drop

Cross Country Healthcare, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Investor sentiment deteriorates as stock falls 22%

Insider recently sold €122k worth of stock

Third quarter 2023 earnings released: EPS: US$0.37 (vs US$0.94 in 3Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Cross Country Healthcare, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: US$0.60 (vs US$1.41 in 2Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Updates Earnings Guidance for the Year 2023

Cross Country Healthcare, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Cross Country Launches New Xperience App, Creating Comprehensive and Intuitive Job Searching Experience for Healthcare Professionals

First quarter 2023 earnings released: EPS: US$0.82 (vs US$1.67 in 1Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Full year 2022 earnings released: EPS: US$5.09 (vs US$3.60 in FY 2021)

Investor sentiment improves as stock rises 15%

Cross Country Healthcare, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Cross Country Healthcare, Inc. Appoints Eric Christianson as Its SVP, Intellify Solutions

Cross Country Healthcare, Inc. Appoints Dwayne L. Allen as Board of Directors

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Hireup Leadership Inc.

Investor sentiment deteriorated over the past week

Cross Country Healthcare, Inc. Announces Venkat Bhamidipati as Member of Board of Directors

Cross Country Healthcare, Inc. Promotes James V. Redd III to Senior Vice President and Chief Accounting Officer

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.94 (vs US$0.63 in 3Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Cross Country Healthcare, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare, Inc. Terminates Employment of Buffy S. White as Group President, Workforce solutions

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. Revising Financial Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) has entered into a definitive agreement to acquire Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare Launches the New Crosscountry.Com

President recently bought €101k worth of stock

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) announces an Equity Buyback for $100 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$1.41 (vs US$0.32 in 2Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. Appoints Craig Hoven as Senior Vice President and Managing Consultant of Cejka Search

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Cross Country Healthcare, Inc.(NasdaqGS:CCRN) dropped from Russell 2000 Value-Defensive Index

First quarter 2022 earnings released: EPS: US$1.67 (vs US$0.54 in 1Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Cross Country Healthcare, Inc. to Report Q1, 2022 Results on May 04, 2022

Cross Country Healthcare Appoints Daniel J. White to New Chief Commercial Officer

Cross Country Healthcare, Inc., Annual General Meeting, May 17, 2022

Chief Administrative Officer recently sold €333k worth of stock